National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

curcumin
A phytopolylphenol pigment isolated from the plant Curcuma longa, commonly known as turmeric, with a variety of pharmacologic properties. Curcumin blocks the formation of reactive-oxygen species, possesses anti-inflammatory properties as a result of inhibition of cyclooxygenases (COX) and other enzymes involved in inflammation; and disrupts cell signal transduction by various mechanisms including inhibition of protein kinase C. These effects may play a role in the agent's observed antineoplastic properties, which include inhibition of tumor cell proliferation and suppression of chemically induced carcinogenesis and tumor growth in animal models of cancer. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:C.I. Natural Yellow 3
Diferuloylmethane
Turmeric Yellow
Abbreviation:CU
Code name:C.I. 75300
Chemical structure name:(E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione



Previous:CS-1008, Cubicin, Culturelle, Cuprenil, Cuprimine
Next:curcumin/green tea extract/Polygonum cuspidatum extract/soybean extract capsule, Curretab, custirsen sodium, CXCR4 inhibitor MSX-122, cycloleucine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov